Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of agrochemicals and bioactive molecules. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for constructing cyclobutane-based scaffolds. The difluoromethoxy group enhances metabolic stability and lipophilicity, which can improve the pharmacokinetic properties of drug candidates. It is also employed in research settings to explore structure-activity relationships in new chemical entities.